Name | Indolapril hydrochloride |
---|---|
Synonyms |
(2S-(1-(R*(R*)),2α,3aβ,7aβ))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indole-2-carboxylic acid hydrochloride
indolapril Hydrochloride {2S-[1-(R*(R*)),2α,3aβ,7aβ]}-1-(2-{[1-(ethoxycarbonyl)-3-phenylpropyl]amino}-1-oxopropyl)octahydro-1H-indole-2-carboxylic acid hydrochloride [1-[(2R,3aS,7aS)-2-carboxy-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-1-oxopropan-2-yl]-(1-ethoxy-1-oxo-4-phenylbutan-2-yl)azanium chloride |
Description | Indolapril hydrochloride (CI-907) is an orally active nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor. Indolapril hydrochloride is highly specific in suppressing the contractile or pressor responses to Angiotensin I. Indolapril hydrochloride is a potent antihypertensive agent[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C24H35ClN2O5 |
---|---|
Molecular Weight | 466.99800 |
Exact Mass | 466.22300 |
PSA | 95.94000 |
LogP | 3.90410 |